SPERO THERAPEUTICS, INC.: cash_and_equivalents
| Value | {"amount": 77690000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2023-06-30) |
| Status | current |
| Entity | SPERO THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:24:46.692812+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/83c5d2b9-d57b-4823-a508-1afe5c265635
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-23-041314Retrieved: 2026-08-19T17:24:46.692812+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001701108/cash-and-equivalents/2023-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/83c5d2b9-d57b-4823-a508-1afe5c265635
History
- no predecessors — first report